(Q40490199)

21 September 2017

title

Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice (English)

1 reference

21 September 2017

1 reference

I V Subramanian

1

1 reference

21 September 2017

R Ghebre

series ordinal

2

1 reference

21 September 2017

S Ramakrishnan

series ordinal

3

1 reference

21 September 2017

publication date

1 January 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

12

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

30-38

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302352

21 September 2017

exact match

0 references

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Vascular endothelial growth factor expression in early stage ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Malignant ascites: a 2-year review from a teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Inhibition of angiogenesis by interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Targeted therapy for epithelial ovarian cancer: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Adenovirus-mediated thymidine kinase gene therapy in combination with topotecan for patients with recurrent ovarian cancer: 2.5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Improved biological activity of a mutant endostatin containing a single amino-acid substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

inferred from DOI database lookup

7 January 2021

based on heuristic

Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302352

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302352

1 reference

Dimensions Publication ID

21 September 2017

1048015441

0 references

1 reference